Allgens Medical Technology Co LtdSHG 688613 Stock Report

Allgens Medical Technology Co., Ltd. engages in the research, development, production, and sale of biomedical materials and related medical device products. The company is headquartered in Beijing, Beijing and currently employs 146 full-time employees. The company went IPO on 2021-05-21. The Company’s main products are mineralized collagen artificial bone repair products used in orthopedics, oral or plastic surgery, and neurosurgery, including Gejin and BonGold, which are mainly used for filling and regenerative repair of various bone defects in the orthopedics field. Chibei, which are mainly used for filling and regenerating bone defects in oral and orthopedic surgery. And Lurui, which are mainly used for cranial defect filling and regeneration repair in neurosurgery. The firm distributes its products both in the domestic market and to overseas markets.